IL17A and rheumatoid arthritis: Interestingly, weak immunomodulatory properties of ASCs from RA patients, but increased ability to induce IL-17A secretion by T cells, led to the conclusion that the dysfunction of ASC may contribute to RA pathogenesis [186].